M&T Bank’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | – | Sell |
-30,303
| Closed | -$208K | – | 1540 |
|
2019
Q3 | $208K | Sell |
30,303
-1,656
| -5% | -$11.4K | ﹤0.01% | 1405 |
|
2019
Q2 | $295K | Sell |
31,959
-10,775
| -25% | -$99.5K | ﹤0.01% | 1242 |
|
2019
Q1 | $669K | Buy |
42,734
+7,429
| +21% | +$116K | ﹤0.01% | 850 |
|
2018
Q4 | $545K | Sell |
35,305
-2,990
| -8% | -$46.2K | ﹤0.01% | 878 |
|
2018
Q3 | $824K | Sell |
38,295
-1,356
| -3% | -$29.2K | ﹤0.01% | 823 |
|
2018
Q2 | $964K | Buy |
39,651
+918
| +2% | +$22.3K | 0.01% | 773 |
|
2018
Q1 | $662K | Sell |
38,733
-63
| -0.2% | -$1.08K | ﹤0.01% | 904 |
|
2017
Q4 | $734K | Sell |
38,796
-38,907
| -50% | -$736K | ﹤0.01% | 874 |
|
2017
Q3 | $1.37M | Sell |
77,703
-18,523
| -19% | -$326K | 0.01% | 657 |
|
2017
Q2 | $3.2M | Sell |
96,226
-11,457
| -11% | -$381K | 0.02% | 429 |
|
2017
Q1 | $3.46M | Sell |
107,683
-12,323
| -10% | -$396K | 0.02% | 403 |
|
2016
Q4 | $4.35M | Sell |
120,006
-44,141
| -27% | -$1.6M | 0.03% | 347 |
|
2016
Q3 | $7.55M | Sell |
164,147
-128,758
| -44% | -$5.92M | 0.05% | 252 |
|
2016
Q2 | $14.7M | Buy |
292,905
+10,063
| +4% | +$505K | 0.1% | 192 |
|
2016
Q1 | $15.1M | Sell |
282,842
-648
| -0.2% | -$34.7K | 0.1% | 189 |
|
2015
Q4 | $18.6M | Sell |
283,490
-18,908
| -6% | -$1.24M | 0.12% | 167 |
|
2015
Q3 | $17.1M | Sell |
302,398
-12,832
| -4% | -$724K | 0.12% | 172 |
|
2015
Q2 | $18.6M | Sell |
315,230
-7,104
| -2% | -$420K | 0.11% | 163 |
|
2015
Q1 | $20.1M | Buy |
322,334
+8,698
| +3% | +$542K | 0.13% | 153 |
|
2014
Q4 | $18M | Buy |
313,636
+10,696
| +4% | +$615K | 0.11% | 158 |
|
2014
Q3 | $16.3M | Buy |
302,940
+285,137
| +1,602% | +$15.3M | 0.1% | 167 |
|
2014
Q2 | $933K | Sell |
17,803
-346
| -2% | -$18.1K | 0.04% | 307 |
|
2014
Q1 | $959K | Sell |
18,149
-8,117
| -31% | -$429K | 0.04% | 289 |
|
2013
Q4 | $1.05M | Buy |
26,266
+4,138
| +19% | +$166K | 0.04% | 265 |
|
2013
Q3 | $836K | Buy |
22,128
+768
| +4% | +$29K | 0.04% | 266 |
|
2013
Q2 | $837K | Buy |
+21,360
| New | +$837K | 0.04% | 276 |
|